Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern

SARS-CoV-2 has caused the COVID-19 pandemic, with over 673 million infections and 6.85 million deaths globally. Novel mRNA and viral-vectored vaccines were developed and licensed for global immunizations under emergency approval. They have demonstrated good safety and high protective efficacy agains...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Fattah Yahaya, Abdul Aziz, Khalid, Kanwal, Lim, Hui Xuan, Poh, Chit Laa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057551/
https://www.ncbi.nlm.nih.gov/pubmed/36992333
http://dx.doi.org/10.3390/v15030624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057551/
https://www.ncbi.nlm.nih.gov/pubmed/36992333
http://dx.doi.org/10.3390/v15030624

Ejemplares similares